Regulation of subcellular localization of the aryl hydrocarbon receptor (AhR)

Archives of Biochemistry and Biophysics
C A RichterM Hannink

Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxicity of dioxin and other xenobiotics. In the absence of exogenous ligand, AhR is cytosolic. We investigated how AhR is retained in the cytosol and how dioxin induces AhR to move to the nucleus. Disruption of nuclear export of AhR by the nuclear export inhibitor leptomycin B (LMB) or by mutation of the AhR nuclear export signal resulted in nuclear accumulation of AhR in the absence of exogenous ligand. Mutation of the AhR nuclear localization signal resulted in defects in nuclear import of AhR in both the presence and the absence of exogenous ligand. Dioxin treatment caused a more rapid accumulation of AhR in the nucleus than LMB treatment. In the presence of both dioxin and LMB, nuclear accumulation of AhR was more rapid than in the presence of dioxin alone. Our results show that AhR shuttles between the nucleus and the cytosol in the absence of exogenous ligand. Binding of ligand induces an increase in the rate of nuclear import of AhR but does not eliminate nuclear export of AhR.

References

Apr 15, 1992·Biochemical and Biophysical Research Communications·M EmaY Fujii-Kuriyama
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K M BurbachC A Bradfield
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P B JonesJ P Whitlock
Mar 22, 1985·Science·P B JonesJ P Whitlock
Dec 1, 1985·Molecular and Cellular Biology·G I EvanJ M Bishop
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·O Hankinson
Sep 1, 1994·Molecular and Cellular Biology·S Reisz-PorszaszO Hankinson
Jul 1, 1996·Physiological Reviews·D A Jans, S Hübner
Mar 1, 1997·Critical Reviews in Toxicology·J C Rowlands, J A Gustafsson
Apr 25, 1997·The Journal of Biological Chemistry·L A Carver, C A Bradfield
Apr 1, 1997·Current Opinion in Genetics & Development·M S Lee, P A Silver
Jul 14, 1997·The Journal of Cell Biology·D GörlichE Izaurralde
Oct 6, 1997·Science·B Ossareh-NazariC Dargemont
Jan 7, 1998·Molecular and Cellular Biology·C Y Chang, A Puga
Feb 28, 1998·The Journal of Biological Chemistry·T IkutaK Kawajiri
Mar 14, 1998·Journal of Biochemistry·K Sogawa, Y Fujii-Kuriyama
Jun 13, 1998·Archives of Biochemistry and Biophysics·D M PhelanM S Denison
Jul 31, 1998·Experimental Cell Research·N KudoM Yoshida
Oct 6, 1998·Annual Review of Biochemistry·I W Mattaj, L Englmeier
May 20, 1999·Annual Review of Pharmacology and Toxicology·J P Whitlock
Jul 8, 1999·Current Opinion in Cell Biology·S A Adam
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·N KudoS Horinouchi
Oct 6, 1999·Current Opinion in Genetics & Development·S T Crews, C M Fan
Feb 29, 2000·The Journal of Biological Chemistry·J J LaPresC A Bradfield
Mar 25, 2000·Journal of Biochemistry·T IkutaK Kawajiri

❮ Previous
Next ❯

Citations

Jun 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Barbara Oesch-BartlomowiczFranz Oesch
Sep 6, 2002·Chemico-biological Interactions·John R Petrulis, Gary H Perdew
May 7, 2009·Expert Opinion on Drug Metabolism & Toxicology·Anwar Anwar-MohamedAyman Os El-Kadi
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N J HewittS S Ferguson
Apr 7, 2007·FEBS Letters·Robert BaroukiPedro M Fernandez-Salguero
Jul 14, 2010·Frontiers in Neuroendocrinology·Jere LindénRaimo Pohjanvirta
Nov 18, 2008·Biochemical Pharmacology·Barbara Oesch-Bartlomowicz, Franz Oesch
Sep 23, 2008·Biochemical Pharmacology·Simone Kobe de Oliveira, Albert Smolenski
Mar 29, 2002·Environmental and Molecular Mutagenesis·Brandon D JeffyDonato F Romagnolo
Dec 14, 2002·Journal of Biochemical and Molecular Toxicology·David B Carlson, Gary H Perdew
Sep 29, 2017·American Journal of Respiratory Cell and Molecular Biology·Afshan DeanMargaret R MacLean
Jul 3, 2003·The Journal of Biological Chemistry·Michael J LeesMurray L Whitelaw
Jun 20, 2019·International Journal of Molecular Sciences·Matti Viluksela, Raimo Pohjanvirta
Nov 20, 2018·EFSA Journal·UNKNOWN EFSA Panel on Contaminants in the Food Chain (CONTAM)Laurentius Ron Hoogenboom
Jul 11, 2020·Pathology Oncology Research : POR·Cristina Díaz Del ArcoMª Jesús Fernández Aceñero
Nov 30, 2018·International Journal of Molecular Sciences·Anaïs WakxIoana Ferecatu
Sep 1, 2010·Expert Review of Endocrinology & Metabolism·Joshua W CainMárta Korbonits
Apr 26, 2020·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ai Hayashi, Michael S Denison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.